Danwen Huang

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Icos Corporation, Eli Lilly and Company, Deltagen Research Labs, LLC. Active years: 2005-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Danwen Huang. Retrieved from https://idiyas.com/inventor/danwen-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 87.5

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 5.5

ph-index = 10

Forward Citations = 441(Granted Patents)

Location History:

Sammamish, WA (US) (2005 - 2014)
Bellevue, WA (US) (2015 - 2021)

Company Filing History:

Eli Lilly and Company

patents

1 out of 1

Deltagen Research Labs, LLC

patent

4. 1 out of 123

Myriad Genetics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2005-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10906907 - Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof (2021-02-02),

2. 10781202 - Azetidinyloxyphenylpyrrolidine compounds (2020-09-22),

3. 10336756 - (S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta (2019-07-02),

4. 9604967 - Azetidinyloxyphenylpyrrolidine compounds (2017-03-28),

5. 9149477 - 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2015-10-06),

6. 9034864 - Azetidinyloxyphenylpyrrolidine compounds (2015-05-19),

7. 8993583 - 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta (2015-03-31),

8. 8980901 - 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta (2015-03-17),

9. 8779131 - 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2014-07-15),

10. RE44638 - Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (2013-12-09),

11. 8586597 - 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta (2013-11-19),

12. RE44599 - Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (2013-11-11),

13. 8207153 - Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (2012-06-26),

14. 7932260 - Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (2011-04-26),

15. 7345040 - Reverse-turn mimetics and compositions and methods relating thereto (2008-03-18),

Title: Danwen Huang - Pioneering Inventor from Bellevue, WA

Introduction: Danwen Huang is a highly accomplished inventor based in Bellevue, Washington. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of patents and inventions.

Latest Patents: Danwen Huang holds several patents in various industries, showcasing his diverse expertise and innovative mindset. His recent patents focus on cutting-edge technologies that have the potential to revolutionize their respective fields.

Career Highlights: Throughout his career, Danwen Huang has demonstrated a remarkable ability to translate ideas into tangible inventions. His dedication to research and development has led to the creation of groundbreaking solutions that address real-world challenges.

Collaborations: Danwen Huang has collaborated with leading companies, research institutions, and universities to further his innovative projects. His partnerships have been instrumental in bringing his inventions to life and maximizing their impact on society.

Conclusion: Danwen Huang's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a standout figure in the world of inventors. His work continues to inspire and shape the future of technology, leaving a lasting legacy in the realm of patents and inventions.

Profile summary based on public USPTO records.